Quick Answer
Caris Life Sciences, Inc. reported Total Assets of $1.13 billion for fiscal year 2025.
Caris Life Sciences, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $1.13B | +227.5% |
| 2024 | $343.73M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $984.57M | — | +3.1% |
| June 30, 2025 | $955.06M | — | +177.8% |
| December 31, 2024 | $343.73M | — | — |
- Caris Life Sciences, Inc. showed an increase of +227.5% in Total Assets compared to the prior fiscal year.
- Over the 2024–2025 period, Caris Life Sciences, Inc.’s total assets has grown by 227.5% (from $343.73 million to $1.13 billion).
- The most recent figure is from Caris Life Sciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: